ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00175110
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : December 3, 2009
Sponsor:
Collaborators:
Celestial Seasonings
Tufts Medical Center
Information provided by:
Tufts University

Brief Summary:
The goal of this study is to find out whether the plant compounds present in Hibiscus sabdariffa, a plant commonly used in herbal tea blends and other beverages, will have a beneficial effect on blood pressure in people with mildly elevated blood pressure.

Condition or disease Intervention/treatment Phase
Hypertension Behavioral: herbal therapy/botanical therapy (Hibiscus sabdariffa) Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 66 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: The Effect of Hibiscus Sabdariffa L. Tisane on Blood Pressure in Prehypertensive and Mildly Hypertensive Men and Women
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Systolic blood pressure 120-150 mm Hg
  • Diastolic blood pressure 95 mm Hg or less
  • Body mass index (BMI) 18.5-34.9 kg/m2

Exclusion Criteria:

  • Smoking
  • Use of medications that influence blood pressure
  • Cardiovascular disease
  • Chronic kidney disease
  • Diabetes
  • Regular use of vitamin C supplements (min 500 mg/day) within prior 30 days
  • Regular strenuous aerobic activity greater than 30 min/day
  • Excessive intake of caffeine or alcohol
  • Pregnancy within last 6 months or during study period
  • Abnormal complete blood count (CBC), urinalysis or electrocardiogram (EKG)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00175110


Locations
United States, Massachusetts
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States, 02111
Sponsors and Collaborators
Tufts University
Celestial Seasonings
Tufts Medical Center
Investigators
Principal Investigator: Jeffrey B Blumberg, Ph.D. Tufts Medical Center

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jeffrey B. Blumberg, Tufts University
ClinicalTrials.gov Identifier: NCT00175110     History of Changes
Other Study ID Numbers: PV3727
First Posted: September 15, 2005    Key Record Dates
Last Update Posted: December 3, 2009
Last Verified: December 2009

Keywords provided by Tufts University:
pre-hypertension
mild hypertension

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases